Oncotelic Therapeutics, Inc. — Revenue by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/eddec954-bf58-40e1-b21f-89b09c35dde0/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2023 | $70.0k | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-014475 |
| FY 2020 | $1.7M | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-008920 |
| FY 2013 | $95.0k | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-108092 |
| FY 2012 | $156.0k | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-110175 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Oncotelic Therapeutics, Inc. — all facts · Net Income · Operating Income